CCL20 and neoplasm: Other studies have demonstrated that CCL20 may also attract T helper 17 (Th17) lymphocytes in EC (90), thereby recruiting DCs to promote the activation of CD8+ T cells and enhance anti-tumor immunity (91, 92).